These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13666408)

  • 1. Metabolic half-life times, blood levels, potencies and activity patterns of metahexamide and other sulfonylurea compounds.
    KNAUFF RE; FAJANS SS; RAMIREZ E; CONN JW
    Metabolism; 1959 Jul; 8(4 Pt 2):606-13. PubMed ID: 13666408
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the half life of metahexamide in normal humans.
    MORGENSTERN LL; GARRETT ER
    Ann N Y Acad Sci; 1959 Sep; 82():502-7. PubMed ID: 14424136
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparison of metahexamide with other oral hypoglycemic agents.
    DOBSON HL; GUILAK H; SCOGIN J; CARTER RE
    Metabolism; 1959 Jul; 8(4 Pt 2):659-66. PubMed ID: 13666413
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of metahexamide in human plasma.
    FORIST AA
    Ann N Y Acad Sci; 1959 Sep; 82():496-501. PubMed ID: 13823959
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology and pharmacology of metahexamide.
    ROOT MA; ANDERSON RC; WELLES JS
    Metabolism; 1959 Jul; 8(4 Pt 2):565-76. PubMed ID: 13666403
    [No Abstract]   [Full Text] [Related]  

  • 6. Metahexamide in diabetes therapy.
    MOSS JM; DELAWTER D
    Ann N Y Acad Sci; 1959 Sep; 82():614-7. PubMed ID: 14424617
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of metahexamide in the treatment of patients with diabetes mellitus.
    WELLER C; MACAULAY A; LINDER M; TRACY JD
    Metabolism; 1959 Jul; 8(4 Pt 2):672-5. PubMed ID: 13666415
    [No Abstract]   [Full Text] [Related]  

  • 8. [New compounds and reactions of sulfonamides with amines. XVI. Preparation and study of hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-N'[(1-pyrazolyl) -alkyl] urea].
    Brzozowski Z; Pac-Pomarnacka E; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(4):461-7. PubMed ID: 970168
    [No Abstract]   [Full Text] [Related]  

  • 9. Some physiologic and therapeutic effects of the hypoglycemic agent, metahexamide, in group of 13 elderly diabetic men.
    BAUER HG; SISLER EB; KUNG YT; McGAVACK TH
    Metabolism; 1959 Jul; 8(4 Pt 2):644-54. PubMed ID: 13666412
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical studies with metahexamide.
    SUGAR SJ; THOMAS LJ
    Ann N Y Acad Sci; 1959 Sep; 82():618-23. PubMed ID: 13835564
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory and clinical observations with a new sulfonylurea.
    SILVER AA; WISHINSKY H; CAPLAN RF; MONK C
    Ann N Y Acad Sci; 1959 Sep; 82():624-31. PubMed ID: 14446734
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of relative hypoglycemic potencies and metabolic effects of metahexamide, chlorpropamide and tolbutamide in diabetes mellitus.
    IZZO JL
    Metabolism; 1959 Jul; 8(4 Pt 2):621-30. PubMed ID: 13666410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Criteria for selection of diabetics to be treated with oral hypoglycemic drugs; test for sensitivity to sulfonylurea compounds].
    ARDUINO F
    Med Cir Farm; 1957 May; (253):187-98. PubMed ID: 13450825
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary observations on the effect of intravenous injections of metahexamide on plasma unesterified fatty acid and other lipids in mild diabetics and nondiabetics.
    WALKER G; KINSELL LW
    Metabolism; 1959 Jul; 8(4 Pt 2):614-9. PubMed ID: 13666409
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the mode of action of insulin and metahexamide.
    GALANSINO G; KANAMEISHI D; BERLINGER FG; FOA PP
    Metabolism; 1959 Jul; 8(4 Pt 2):587-92. PubMed ID: 13666406
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML; Visser LE; Trienekens PH; Hofman A; van Schaik RH; Stricker BH
    Clin Pharmacol Ther; 2008 Feb; 83(2):288-92. PubMed ID: 17597710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic trials with metahexamide in diabetes].
    CONCHA E; JIMENEZ E
    Rev Med Chil; 1960 Dec; 88():978-80. PubMed ID: 13694969
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical comparison of tolbutamide, chlorpropamide and metahexamide in the treatment of diabetes.
    OWEN JA
    Metabolism; 1959 Jul; 8(4 Pt 2):667-71. PubMed ID: 13666414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.